Department of Imaging and Interventional Radiology and Division of Neurosurgery, Department of Surgery, the Chinese University of Hong Kong, Prince of Wales Hospital, 30-32 Ngan Shing Street, Room 2A061, 2/F, New Extension Block, Shatin, New Territories, Hong Kong.
Radiology. 2012 Dec;265(3):893-901. doi: 10.1148/radiol.12120422. Epub 2012 Sep 20.
To evaluate the midterm clinical and angiographic outcomes after pipeline embolization device (PED) placement for treatment of intracranial aneurysms.
This prospective nonrandomized multicenter study was approved by the review boards of all involved centers; informed consent was obtained. Patients (143 patients, 178 aneurysms) with unruptured saccular or fusiform aneurysms or recurrent aneurysms after previous treatment were included and observed angiographically for up to 18 months and clinically for up to 3 years. Study endpoints included complete aneurysm occlusion; neurologic complications within 30 days and up to 3 years; clinical outcome of cranial nerve palsy after PED placement; angiographic evidence of occlusion or stenosis of parent artery and that of occlusion of covered side branches at 6, 12, and 18 months; and clinical and computed tomographic evidence of perforator infarction.
There were five (3.5%) cases of periprocedural death or major stroke (modified Rankin Scale [mRS] > 3) (95% confidence interval [CI]: 1.3%, 8.4%), including two posttreatment delayed ruptures, two intracerebral hemorrhages, and one thromboembolism. Five (3.5%) patients had minor neurologic complications within 30 days (mRS = 1) (95% CI: 1.3%, 8.4%), including transient ischemic attack (n = 2), small cerebral infarction (n = 2), and cranial nerve palsy (n = 1). Beyond 30 days, there was one fatal intracerebral hemorrhage and one transient ischemic attack. Ten of 13 patients (95% CI: 46%, 93.8%) completely recovered from symptoms of cranial nerve palsy within a median of 3.5 months. Angiographic results at 18 months revealed a complete aneurysm occlusion rate of 84% (49 of 58; 95% CI: 72.1%, 92.2%), with no cases of parent artery occlusion, parent artery stenosis (<50%) in three patients, and occlusion of a covered side branch in two cases (posterior communicating arteries). Perforator infarction did not occur.
PED placement is a reasonably safe and effective treatment for intracranial aneurysms. The treatment is promising for aneurysms of unfavorable morphologic features, such as wide neck, large size, fusiform morphology, incorporation of side branches, and posttreatment recanalization, and should be considered a first choice for treating unruptured aneurysms and recurrent aneurysms after previous treatments.
http://radiology.rsna.org/lookup/suppl/doi:10.1148/radiol.12120422/-/DC1.
评估Pipeline 栓塞装置(PED)治疗颅内动脉瘤的中期临床和血管造影结果。
本前瞻性非随机多中心研究获得所有参与中心的审查委员会批准;获得了知情同意。纳入了未破裂的囊状或梭形动脉瘤或先前治疗后复发的动脉瘤患者,并在 18 个月内进行血管造影观察,3 年内进行临床观察。研究终点包括完全动脉瘤闭塞;30 天内和 3 年内的神经并发症;PED 放置后颅神经麻痹的临床结果;6、12 和 18 个月时母动脉闭塞和覆盖的侧支闭塞的血管造影证据;以及穿支梗死的临床和计算机断层扫描证据。
有 5 例(3.5%)围手术期死亡或大卒中(改良 Rankin 量表[mRS]>3)(95%置信区间[CI]:1.3%,8.4%),包括 2 例治疗后迟发性破裂、2 例颅内出血和 1 例血栓栓塞。5 例(3.5%)患者在 30 天内出现轻微神经并发症(mRS=1)(95%CI:1.3%,8.4%),包括短暂性脑缺血发作(n=2)、小面积脑梗死(n=2)和颅神经麻痹(n=1)。30 天后,有 1 例颅内出血致死,1 例短暂性脑缺血发作。13 例患者中有 10 例(95%CI:46%,93.8%)的颅神经麻痹症状在中位数为 3.5 个月内完全恢复。18 个月时的血管造影结果显示完全动脉瘤闭塞率为 84%(58 例中的 49 例;95%CI:72.1%,92.2%),无母动脉闭塞病例,3 例母动脉狭窄(<50%),2 例覆盖的侧支闭塞(后交通动脉)。未发生穿支梗死。
PED 放置是颅内动脉瘤一种合理安全且有效的治疗方法。该治疗方法对形态学特征不利的动脉瘤具有良好的治疗前景,例如宽颈、大尺寸、梭形形态、合并侧支和治疗后再通等,应考虑作为未破裂动脉瘤和先前治疗后复发动脉瘤的首选治疗方法。
http://radiology.rsna.org/lookup/suppl/doi:10.1148/radiol.12120422/-/DC1.